Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 3
1979 6
1980 14
1981 35
1982 69
1983 45
1984 68
1985 42
1986 48
1987 31
1988 26
1989 19
1990 20
1991 15
1992 13
1993 9
1994 6
1995 9
1996 14
1997 9
1998 10
1999 9
2000 9
2001 10
2002 3
2003 6
2004 9
2005 6
2006 10
2007 9
2008 7
2009 2
2010 6
2011 6
2012 10
2013 5
2014 8
2015 6
2016 3
2017 2
2018 4
2019 4
2020 5
2021 4
2022 3
2023 4
2024 3
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

655 results

Results by year

Filters applied: . Clear all
Page 1
Cefsulodin.
Wright DB. Wright DB. Drug Intell Clin Pharm. 1986 Nov;20(11):845-9. doi: 10.1177/106002808602001104. Drug Intell Clin Pharm. 1986. PMID: 3536385 Review.
The chemistry, microbiology, pharmacokinetics, adverse reactions, and clinical indications for cefsulodin are reviewed and compared to ceftazidime and cefoperazone. Cefsulodin is a narrow-spectrum, third-generation cephalosporin with activity virtually restricted to …
The chemistry, microbiology, pharmacokinetics, adverse reactions, and clinical indications for cefsulodin are reviewed and compared t …
Activity of cefsulodin and other agents against Pseudomonas aeruginosa.
Neu HC, Scully BE. Neu HC, et al. Rev Infect Dis. 1984 Sep-Oct;6 Suppl 3:S667-77. doi: 10.1093/clinids/6.supplement_3.s667. Rev Infect Dis. 1984. PMID: 6443768 Review.
Cefsulodin has a high affinity for penicillin-binding proteins of Pseudomonas aeruginosa but binds poorly to those of other bacteria. ...Cefsulodin acts synergistically with all aminoglycosides against 20%-80% of P. aeruginosa isolates....
Cefsulodin has a high affinity for penicillin-binding proteins of Pseudomonas aeruginosa but binds poorly to those of other bacteria. …
Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
Smith BR. Smith BR. Clin Pharm. 1984 Jul-Aug;3(4):373-85. Clin Pharm. 1984. PMID: 6380902 Review.
The microbiologic, pharmacokinetic, and clinical profiles of cefsulodin and ceftazidime are reviewed. Ceftazidime is a broad-spectrum beta-lactamase stable cephalosporin with excellent activity against gram-negative bacilli, including Pseudomonas aeruginosa. Cefsulodin …
The microbiologic, pharmacokinetic, and clinical profiles of cefsulodin and ceftazidime are reviewed. Ceftazidime is a broad-spectrum …
Cefsulodin kinetics in renal impairment.
Gibson TP, Granneman GR, Kallal JE, Sennello LT. Gibson TP, et al. Clin Pharmacol Ther. 1982 May;31(5):602-8. doi: 10.1038/clpt.1982.84. Clin Pharmacol Ther. 1982. PMID: 7075110
Cefsulodin kinetics were determined after a 500-mg dose to normal subjects and patients with varying degrees of renal insufficiency, including those requiring hemodialysis. ...Therefore, renal failure reduces the ClT of cefsulodin. In hemodialysis patients the maint …
Cefsulodin kinetics were determined after a 500-mg dose to normal subjects and patients with varying degrees of renal insufficiency, …
[Cefsulodin (Monaspor)].
Friis H, Holten-Andersen W. Friis H, et al. Ugeskr Laeger. 1986 Jun 23;148(26):1618-9. Ugeskr Laeger. 1986. PMID: 3750440 Danish. No abstract available.
Cefsulodin and Vancomycin: A Supplement for Chromogenic Coliform Agar for Detection of Escherichia coli and Coliform Bacteria from Different Water Sources.
Schalli M, Inwinkl SM, Platzer S, Baumert R, Reinthaler FF, Ofner-Kopeinig P, Haas D. Schalli M, et al. Microorganisms. 2022 Dec 16;10(12):2499. doi: 10.3390/microorganisms10122499. Microorganisms. 2022. PMID: 36557752 Free PMC article.
For this reason, an alternative method with a Cefsulodin/Vancomycin (CV)-supplemented CCA should be evaluated regarding its application in water from different sources. ...
For this reason, an alternative method with a Cefsulodin/Vancomycin (CV)-supplemented CCA should be evaluated regarding its applicati …
Cefsulodin sodium therapy in cystic fibrosis patients.
Cabezudo I, Thompson RL, Selden RF, Guenthner SH, Wenzel RP. Cabezudo I, et al. Antimicrob Agents Chemother. 1984 Jan;25(1):4-6. doi: 10.1128/AAC.25.1.4. Antimicrob Agents Chemother. 1984. PMID: 6422844 Free PMC article. Clinical Trial.
Cefsulodin sodium is a narrow-spectrum cephalosporin with marked in vitro activity against clinical isolates of Pseudomonas aeruginosa. ...Detectable levels of cefsulodin in sputa were found in approximately half of the random samples and ranged from 2 to 5 microgra …
Cefsulodin sodium is a narrow-spectrum cephalosporin with marked in vitro activity against clinical isolates of Pseudomonas aeruginos …
Antipseudomonal beta-lactams.
Slack MP. Slack MP. J Antimicrob Chemother. 1981 Sep;8(3):165-70. doi: 10.1093/jac/8.3.165. J Antimicrob Chemother. 1981. PMID: 6270049 Free article. Review. No abstract available.
Cefsulodin therapy for infections due to Pseudomonas aeruginosa in patients with burns.
Heimbach DM. Heimbach DM. Rev Infect Dis. 1984 Sep-Oct;6 Suppl 3:S744-50. doi: 10.1093/clinids/6.supplement_3.s744. Rev Infect Dis. 1984. PMID: 6443775 Clinical Trial.
Rates of bacteriologic cure for 30 sites of infection were 64% (7/11) for skin and skin-structure infections treated with cefsulodin or reference antibiotics; 100% (1/1) for respiratory tract infections treated with cefsulodin and 33% (2/6) for those treated with re …
Rates of bacteriologic cure for 30 sites of infection were 64% (7/11) for skin and skin-structure infections treated with cefsulodin …
Cefsulodin in treatment of Pseudomonas urinary tract infection in patients with spinal cord injury. Comparison with aminoglycosides.
Montgomerie JZ, Morrow JW, Canawati HN, Gilmore DS, Graham IE, Ibraham MZ. Montgomerie JZ, et al. Urology. 1986 Nov;28(5):446-50. doi: 10.1016/0090-4295(86)90087-7. Urology. 1986. PMID: 3787915
At five to nine days after completing treatment P. aeruginosa was eliminated from the urine of 12 to 15 patients (80%) treated with cefsulodin and 3 of 6 patients (50%) treated with an aminoglycoside. When examined at four to six weeks 5 of 15 (33%) of the cefsulodin …
At five to nine days after completing treatment P. aeruginosa was eliminated from the urine of 12 to 15 patients (80%) treated with cefsu …
655 results